Tilray Brands Files 8-K with Financial Updates
Ticker: TLRY · Form: 8-K · Filed: 2025-04-08T00:00:00.000Z
Sentiment: neutral
Topics: financial-results, operations, sec-filing
Related Tickers: TLRY
TL;DR
Tilray Brands dropped its latest 8-K on April 8th – check the financials!
AI Summary
On April 8, 2025, Tilray Brands, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, providing an update on the company's performance. The report is filed under the 1934 Act with SEC file number 001-38594.
Why It Matters
This filing provides investors with crucial, up-to-date financial information and operational details for Tilray Brands, Inc., enabling informed investment decisions.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant financial and operational news that may impact stock price, requiring careful investor review.
Key Players & Entities
- Tilray Brands, Inc. (company) — Registrant
- 001-38594 (company) — SEC File Number
- April 8, 2025 (date) — Date of earliest event reported
- 265 Talbot Street West Leamington , Ontario N8H 4H3 (address) — Principal Executive Offices
- 844 ) 845-7291 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Tilray Brands, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, along with providing Financial Statements and Exhibits.
What is the SEC file number for Tilray Brands, Inc.?
The SEC file number for Tilray Brands, Inc. is 001-38594.
On what date was this 8-K report filed or effective?
The report was filed as of April 8, 2025, and the date of the earliest event reported is also April 8, 2025.
What is the principal executive office address for Tilray Brands, Inc.?
The principal executive office address is 265 Talbot Street West Leamington, Ontario N8H 4H3.
What is the IRS Employer Identification Number (EIN) for Tilray Brands, Inc.?
The IRS Employer Identification Number (EIN) for Tilray Brands, Inc. is 82-4310622.
From the Filing
0001171843-25-002081.txt : 20250408 0001171843-25-002081.hdr.sgml : 20250408 20250408070013 ACCESSION NUMBER: 0001171843-25-002081 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250408 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250408 DATE AS OF CHANGE: 20250408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 25820255 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K 1 f8k_040825.htm FORM 8-K Form 8-K 0001731348 False 0001731348 2025-04-08 2025-04-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM 8-K _________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  April 8, 2025 _______________________________ Tilray Brands, Inc. (Exact name of registrant as specified in its charter) _______________________________ Delaware 001-38594 82-4310622 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 265 Talbot Street West Leamington , Ontario N8H 4H3 (Address of Principal Executive Offices) (Zip Code) ( 844 ) 845-7291 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) _______________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.0001 per share TLRY The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐     Item 2.02. Results of Operations and Financial Condition. On April 8, 2025, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number   Description       99.1   Press Release dated April 8, 2025 104   Cover Page Interactive Data File (embedded within the Inline XBRL document)     SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed o